Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial.
J Clin Med. 2022 Feb 21;11(4):1139. doi: 10.3390/jcm11041139.
J Clin Med. 2022.
PMID: 35207411
Free PMC article.
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE).
Pérez-Martínez A, Mora-Rillo M, Ferreras C, Guerra-García P, Pascual-Miguel B, Mestre-Durán C, Borobia AM, Carcas AJ, Queiruga-Parada J, García I, Sánchez-Zapardiel E, Gasior M, De Paz R, Marcos A, Vicario JL, Balas A, Moreno MA, Eguizabal C, Solano C, Arribas JR, Buckley RM, Montejano R, Soria B.
Pérez-Martínez A, et al. Among authors: queiruga parada j.
EClinicalMedicine. 2021 Sep;39:101086. doi: 10.1016/j.eclinm.2021.101086. Epub 2021 Aug 13.
EClinicalMedicine. 2021.
PMID: 34405140
Free PMC article.
Item in Clipboard
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol.
García-García I, Guerra-García P, Ferreras C, Borobia AM, Carcas AJ, Queiruga-Parada J, Vicario JL, Mirones I, Solano C, Eguizabal C, Soria B, Pérez-Martínez A.
García-García I, et al. Among authors: queiruga parada j.
Trials. 2021 Oct 2;22(1):674. doi: 10.1186/s13063-021-05625-7.
Trials. 2021.
PMID: 34600562
Free PMC article.
Item in Clipboard
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial.
Montejano R, de la Calle-Prieto F, Velasco M, Guijarro C, Queiruga-Parada J, Jiménez-González M, González-Ruano P, Martínez P, Goikoetxea AJ, Ibarrola M, Ciudad M, Gutiérrez Á, Torralba M, Díaz-Brasero A, Ryan P, Marcelo C, Díez C, Ibarra S, Merino E, Estrada V, Marcos J, Novella M, Rivera MA, Ruiz-Muñoz M, de Miguel M, Soler L, Del Álamo M, Moreno S, Carcas AJ, Borobia AM, Arribas JR; PANCOVID Study Group.
Montejano R, et al. Among authors: queiruga parada j.
Clin Infect Dis. 2023 Feb 8;76(3):e116-e125. doi: 10.1093/cid/ciac628.
Clin Infect Dis. 2023.
PMID: 35906838
Free PMC article.
Clinical Trial.
Item in Clipboard
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210).
Ferreras C, Hernández-Blanco C, Martín-Quirós A, Al-Akioui-Sanz K, Mora-Rillo M, Ibáñez F, Díaz-Almirón M, Cano-Ochando J, Lozano-Ojalvo D, Jiménez-González M, Goterris R, Sánchez-Zapardiel E, de Paz R, Guerra-García P, Queiruga-Parada J, Molina P, Briones ML, Ruz-Caracuel B, Borobia AM, Carcas AJ, Planelles D, Vicario JL, Moreno MÁ, Balas A, Llano M, Llorente A, Del Balzo Á, Cañada C, García MÁ, Calvin ME, Arenas I, Pérez de Diego R, Eguizábal C, Soria B, Solano C, Pérez-Martínez A.
Ferreras C, et al. Among authors: queiruga parada j.
Cytotherapy. 2024 Jan;26(1):25-35. doi: 10.1016/j.jcyt.2023.10.002. Epub 2023 Oct 29.
Cytotherapy. 2024.
PMID: 37897472
Clinical Trial.
Item in Clipboard
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lescure FX, Honda H, Fowler RA, Lazar JS, Shi G, Wung P, Patel N, Hagino O; Sarilumab COVID-19 Global Study Group.
Lescure FX, et al.
Lancet Respir Med. 2021 May;9(5):522-532. doi: 10.1016/S2213-2600(21)00099-0. Epub 2021 Mar 4.
Lancet Respir Med. 2021.
PMID: 33676590
Free PMC article.
Clinical Trial.
Item in Clipboard
A randomized, double-blind, single-dose study to assess bioequivalence of MB02 biosimilar after manufacturing iteration and reference bevacizumab.
Schwabe C, Cole A, Espigares-Correa A, Beydon ME, Florez-Igual A, Queiruga-Parada J.
Schwabe C, et al. Among authors: queiruga parada j.
Pharmacol Res Perspect. 2023 Apr;11(2):e01070. doi: 10.1002/prp2.1070.
Pharmacol Res Perspect. 2023.
PMID: 36914963
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite